You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

CLINICAL TRIALS PROFILE FOR INVERT SUGAR


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for invert sugar

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00896311 ↗ Intravenous (IV) Nitroglycerin for Versions in Nulliparous Women Completed University of Calgary N/A 2003-03-01 Breech presentations (where a baby presents with feet or bottom down) have an increased risk of perinatal and neonatal complications, and are usually delivered by cesarean section. As an alternative, so that the baby can be delivered vaginally, an attempt can be made to turn the baby so that it is head down: this manoeuvre is called an external cephalic version (ECV). Drugs that relax the uterus (tocolytic agents) are sometimes used to help improve ECV success rates. Nitroglycerin is a tocolytic agent, but intravenous nitroglycerin has not been tested as an agent to help ECV. There is some suggestion that nitroglycerin may be more helpful in women who have not previously been pregnant (nulliparous women) than in women who have been pregnant more than once (multiparous women), and so we have planned two trials. This study is designed to answer the following questions for nulliparous women: Will administration of IV nitroglycerin for uterine relaxation improve ECV success rates? Will an increase in ECV success result in a decreased cesarean section rate?
NCT04470479 ↗ Oral Pilocarpine in the Treatment of the Dry Eye of Patients With Sjogrens Syndrome Completed Federal University of São Paulo Phase 3 2005-03-01 The purpose of this study was to access the possible beneficial effects of oral use of pilocarpine in relieving signs and symptoms of patients with Sjogren's syndrome
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for invert sugar

Condition Name

Condition Name for invert sugar
Intervention Trials
Breech Presentation 1
Complication of Pregnancy 1
Dry Eye 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for invert sugar
Intervention Trials
Sjogren's Syndrome 1
Keratoconjunctivitis Sicca 1
Dry Eye Syndromes 1
Pregnancy Complications 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for invert sugar

Trials by Country

Trials by Country for invert sugar
Location Trials
Canada 1
Brazil 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for invert sugar

Clinical Trial Phase

Clinical Trial Phase for invert sugar
Clinical Trial Phase Trials
Phase 3 1
N/A 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for invert sugar
Clinical Trial Phase Trials
Completed 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for invert sugar

Sponsor Name

Sponsor Name for invert sugar
Sponsor Trials
University of Calgary 1
Federal University of São Paulo 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for invert sugar
Sponsor Trials
Other 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.